Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
XOMA Limited - Premium Company Profile (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 24/12/2007
- Report Title: XOMA Limited - Premium Company Profile
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 57
Introduction
XOMA is a biopharmaceutical company focusing on the discovery and development of therapeutic antibodies for the treatment of cancer and immune diseases. The company has a broad technology platform and a fully integrated product development infrastructure for antibodies and other biologics.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
XOMA's technological platform makes the company unique from its competitors. The company's marketed product, Lucentis was developed using its BCE technology and XOMA 052 is the first candidate being developed using another proprietary technology, Human Engineered (HE) technology.
The company derives its revenues from contract, licensing, collaboration and royalties. These include upfront and milestone payments related to the outlicensing agreement with Merck & Co as well as from contracts entered with SPRI, Taligen, AVEO and NIAID, Genentech and Novartis.
During 2006-2010, XOMA's revenues are expected to grow at a CAGR of 39% rising from $29 million to $110 million, over the period 2006-2010, XOMA's biggest contributor to sales growth out to 2010 will be from contract, license and collaboration, forecasted to grow at a CAGR of 43% from $19 million in 2006 to $81 million in 2010.
Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization
Scope
Highlights
Reasons to Purchase
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
